๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer

โœ Scribed by Yoshihiro Hasui; Kousuke Marutsuka; Junji Suzumiya; Shinichiro Kitada; Yukio Osada; Akinobu Sumiyoshi


Publisher
John Wiley and Sons
Year
1992
Tongue
French
Weight
369 KB
Volume
50
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

โœฆ Synopsis


Urokinase

-type plasminogen activator (u-PA) is thought to be implicated in cancer invasion and metastasis. The aim of this study was to determine whether the u-PA content of cancer tissue is a prognostic factor in bladder cancer. Tissue samples from 46 patients with bladder cancer were assessed for u-PA antigen by a highly sensitive enzyme immunoassay. The relationships between the u-PA level in extracts of bladder cancer and the survival rates of the bladder-cancer patients were examined. Patients with a high u-PA level (8 ng/mg of protein and more) showed a statistically significantly higher rate of survival than those with a low u-PA level (p < 0.005). The u-PA antigen level in cancer tissue was significantly lower in low-graded and non-invasive cancers than in others (p < 0.01).


๐Ÿ“œ SIMILAR VOLUMES


Urokinase plasminogen activator: A progn
โœ Duffy, Michael J.; Maguire, Teresa M.; McDermott, Enda W.; O'Higgins, Niall ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 143 KB ๐Ÿ‘ 2 views

Urokinase plasminogen activator (uPA) is a serine protease causally involved in cancer invasion and metastasis. Consistent with its role in cancer spread, uPA has been shown to be a prognostic marker in a variety of malignancies, especially breast cancer. Approximately 20 different groups have shown

Urinary levels of urokinase-type plasmin
โœ Roberto Casella; Shahrokh F. Shariat; Mara A. Monoski; Seth P. Lerner ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 1 views

## Background: The authors found previously that plasma levels of urokinase-type plasminogen activator (upa) and its receptor (upar) were elevated in patients with bladder carcinoma and were associated with features of biologically aggressive disease. in the current study, they tested the hypothesi

The insulin-like growth factor-1 elevate
โœ S.E. Dunn; J.V. Torres; N. Nihei; J.C. Barrett ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 164 KB ๐Ÿ‘ 1 views

Tumor recurrence is a common problem in the treatment of breast cancer. In breast cancer, the expression of high protein levels of the insulin-like growth factor-1 receptor (IGF-1R) and urokinase-type plasminogen activator-1 (uPA) is strongly associated with breast cancer recurrence and decreased su